Market Closed -
Nasdaq
03:59:44 2024-06-04 pm EDT
|
5-day change
|
1st Jan Change
|
238.9
USD
|
-0.39%
|
|
-5.90%
|
-3.35%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
1,216
|
986.9
|
1,834
|
2,968
|
3,265
|
4,495
|
Enterprise Value (EV)
1 |
1,124
|
1,002
|
1,749
|
2,914
|
3,227
|
4,421
|
P/E ratio
|
26.5
x
|
21.4
x
|
40.2
x
|
46
x
|
50.5
x
|
59.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.04
x
|
1.67
x
|
3.32
x
|
4.59
x
|
4.54
x
|
5.65
x
|
EV / Revenue
|
1.89
x
|
1.69
x
|
3.16
x
|
4.51
x
|
4.49
x
|
5.56
x
|
EV / EBITDA
|
13.3
x
|
12
x
|
21.2
x
|
26.9
x
|
29.4
x
|
36.4
x
|
EV / FCF
|
21.1
x
|
29.3
x
|
23.7
x
|
131
x
|
61.8
x
|
80.6
x
|
FCF Yield
|
4.73%
|
3.41%
|
4.23%
|
0.76%
|
1.62%
|
1.24%
|
Price to Book
|
6.21
x
|
5.16
x
|
8.32
x
|
13.9
x
|
16.2
x
|
18.2
x
|
Nbr of stocks (in thousands)
|
18,638
|
18,105
|
17,877
|
17,621
|
17,159
|
17,094
|
Reference price
2 |
65.24
|
54.51
|
102.6
|
168.4
|
190.3
|
263.0
|
Announcement Date
|
6/7/19
|
6/10/20
|
5/28/21
|
5/27/22
|
5/26/23
|
5/24/24
|
Fiscal Period: Marzo |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
595.7
|
592.2
|
552.6
|
646.2
|
718.6
|
795.3
|
EBITDA
1 |
84.5
|
83.23
|
82.61
|
108.4
|
109.7
|
121.4
|
EBIT
1 |
61.51
|
60.71
|
59.18
|
84.51
|
84.55
|
95.1
|
Operating Margin
|
10.33%
|
10.25%
|
10.71%
|
13.08%
|
11.77%
|
11.96%
|
Earnings before Tax (EBT)
1 |
61.51
|
60.71
|
59.18
|
84.51
|
84.55
|
95.1
|
Net income
1 |
46.7
|
47.38
|
46.36
|
66.41
|
66.36
|
76.25
|
Net margin
|
7.84%
|
8%
|
8.39%
|
10.28%
|
9.24%
|
9.59%
|
EPS
2 |
2.460
|
2.550
|
2.550
|
3.660
|
3.770
|
4.400
|
Free Cash Flow
1 |
53.2
|
34.14
|
73.93
|
22.18
|
52.22
|
54.85
|
FCF margin
|
8.93%
|
5.77%
|
13.38%
|
3.43%
|
7.27%
|
6.9%
|
FCF Conversion (EBITDA)
|
62.96%
|
41.03%
|
89.49%
|
20.45%
|
47.61%
|
45.2%
|
FCF Conversion (Net income)
|
113.91%
|
72.07%
|
159.48%
|
33.39%
|
78.69%
|
71.94%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/7/19
|
6/10/20
|
5/28/21
|
5/27/22
|
5/26/23
|
5/24/24
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
1 |
-
|
15.1
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
91.7
|
-
|
85.1
|
54.4
|
37.6
|
74.2
|
Leverage (Debt/EBITDA)
|
-
|
0.1814
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
53.2
|
34.1
|
73.9
|
22.2
|
52.2
|
54.9
|
ROE (net income / shareholders' equity)
|
25.5%
|
24.6%
|
22.6%
|
30.7%
|
32%
|
33.9%
|
ROA (Net income/ Total Assets)
|
13%
|
10.3%
|
8.8%
|
12.6%
|
13.1%
|
14%
|
Assets
1 |
359.6
|
458.4
|
527.1
|
528.1
|
508.1
|
544.3
|
Book Value Per Share
2 |
10.50
|
10.60
|
12.30
|
12.10
|
11.80
|
14.50
|
Cash Flow per Share
2 |
4.940
|
4.630
|
7.820
|
5.550
|
4.150
|
6.160
|
Capex
1 |
15.3
|
32.4
|
17.2
|
29.8
|
26.3
|
29.2
|
Capex / Sales
|
2.56%
|
5.46%
|
3.12%
|
4.61%
|
3.66%
|
3.68%
|
Announcement Date
|
6/7/19
|
6/10/20
|
5/28/21
|
5/27/22
|
5/26/23
|
5/24/24
|
|
1st Jan change
|
Capi.
|
---|
| -2.98% | 4.11B | | +22.91% | 87.14B | | -23.75% | 75.59B | | +0.92% | 26.78B | | +3.88% | 17.89B | | -14.20% | 16.44B | | +2.34% | 15.68B | | +76.91% | 13.06B | | +72.91% | 13.3B | | +38.99% | 12.77B |
Other Healthcare Facilities & Services
|